Form D · Biotechnology
Zenas BioPharma, Inc.
Waltham, MA · CIK 0001953926
Offering snapshot reported May 14, 2024 · SEC filing
- Reported sold
- $200M Offering amount: $200M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 3, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 14, 2024 | Initial | $200,145,732 | No comparison | 26 | SEC filing |
| Nov 15, 2022 | Initial | $183,898,435 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-513274
Source: Form D, filed May 14, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Patricia Allen | Director |
| James Patrick Boylan | Director |
| Patrick Gerald Enright | Director |
| Joseph Farmer | Executive |
| Tanya Z. Fischer | Executive |
| Jennifer Fox | Executive |
| Tomas Kiselak | Director |
| Hongbo Lu | Director |
| Leon O. Moulder, Jr. | Director, Executive |
| Hua Mu | Director, Executive |
| Jake Nunn | Director |
| John Jacob Orloff | Director |
| Marietta Wu | Director |
| Tim Xiao | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1000 Winter St, Suite 1200
Waltham, MA, 02451
Waltham, MA, 02451